Hypertriglyceridemia as a cardiovascular risk factor

American Journal of Cardiology

Volumn 81, Issue 4 A, 1998, Pages 7B-12B

  Austin, Melissa A ^a   Hokanson, John E ^b   Edwards, Karen L ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL RESEARCH; CONFERENCE PAPER; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; META ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; STATISTICAL ANALYSIS;

EID: 0032567990     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00031-9     Document Type: Conference Paper

References (29)

1. Albrink MJ, Man EB. Serum triglycerides in coronary artery disease. Arch Intern Med 1959;103:4-8.
2. Brown DF, Kinch SH, Doyle JT. Serum triglycerides in health and in ischemic heart disease. N Engl J Med 1965;273:947-952.
3. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 1991;11:2-14.
4. NIH Consensus Development Panel on Triglyceride, High Density Lipoprotein, and Coronary Heart Disease. JAMA 1993;269:505-510.
5. Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangdiwala S, Kritchevsky S, Jacobs DR Jr, O'Grady HK, Davis CE. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 1993;328:1220-1225.
6. Hokanson JE, Austin MA. Plasma triglyceride is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213-219.
7. Greenland S. Quantitative methods in the review of epidemiol literature Epidemiol Rev 1987;9:1-30.
8. Hulley SB, Rosenman RH, Bawol RD, Brand RJ. Epidemiology as a guide to clinical decisions: the association between triglyceride and coronary heart disease. N Engl J Med 1980;302:1383-1389.
9. Rosenman RH, Brand RJ, Jenkins CD, Friedman M, Straus R, Wurm M. Coronary heart disease in the Western Collaborative Group Study: final follow-up experience of 81/2 years. JAMA 1975;233:872-877.
10. Bottinger LE, Carlson LA. Risk factors for death for males and females: a study of death pattern in the Stockholm Prospective Study. Acta Med Scand 1982;211:437-442.
11. Wilhelmsen L, Wedel H, Tibblin G. Multivariate analysis of risk factors for coronary heart disease. Circulation 1973;48:950-958.
12. Pelkonen R, Nikkilä EA, Koskinen S, Penttinen K, Sarna S. Association of serum lipids and obesity with cardiovascular mortality. BMJ 1977;2:1185-1187.
13. Cambien F, Jacqueson A, Richard JL, Warnet JM, Ducimetiere P, Claude JR. Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study. Am J Epidemiol 1986;124:624-632.
14. Bengtsson C, Bjorkelund C, Lapidus L, Lissner L. Association of serum lipid concentrations and obesity with mortality in women: 20-year follow-up of participants in prospective population study in Gothenburg, Sweden. BMJ 1993;307: 1385-1388.
15. Aberg H, Lithell H, Selinus I, Hedstrand H. Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris: results from a 10-year follow-up of Uppsala Primary Preventive Study. Atherosclerosis 1985;54:89-97.
16. Wilson P, Larson G, Castelli W. Triglycerides, HDL-cholesterol, and coronary artery disease: a Framingham update on the interactions. Can J Cardiol 1994;10(suppl B):5-9.
17. Salonen JT, Puska P. Relation of serum cholesterol and triglycerides to the risk of acute myocardial infarction, cerebral stroke and death in eastern Finnish male population. Int J Epidemiol 1983;12:26-31.
18. Heyden S, Heiss G, Hames CG, Bartel AG. Fasting triglycerides as predictors of total and CHD mortality in Evans County, Georgia. J Chron Dis 1980;33: 275-282.
19. Glynn RJ, Rosner B, Silbert JE. Changes in cholesterol and triglyceride as predictors of ischemic heart disease. Circulation 1982;66:724-731.
20. Bainton D, Miller NE, Bolton CH, Yarnell JWG, Sweetnam PM, Baker IA, Lewis B, Elwood PC. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men: the Caerphilly and Speedwell Collaborative Heart Disease Studies. Br Heart J 1992;68:60-66.
21. Sigurdsson G, Baldursdottir, Sigvaldason H, Agnarsson U, Thorgeirsson G, Sigfusson N. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Am J Cardiol 1992;69:1251-1254.
22. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglyceride to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol 1992;70:733-737.
23. Menotti A, Spagnolo A, Scanga M, Dima F. Multivariate prediction of coronary disease deaths in a 10-year follow-up of an Italian occupational male cohort. Acta Cardiologica 1992;47:311-320.
24. Menotti A, Scanga M, Morisi G. Serum triglycerides in the prediction of coronary artery disease: an Italian experience. Am J Cardiol 1994;73:29-32.
25. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996;276:882-888.
26. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996;276:875-881.
27. Lamarche B, Tchernof A, Moorjani S, Catin B, Dagenais GR, Lupien PJ, Després J-P. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Circulation 1997;95:69-75.
28. Austin MA, King M-C, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 1990;82:495-506.
29. Assmann G, Schulte H, von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 1996;77:1179-1184.